Caris Life Sciences, Inc.
Close on Nov 20, 2026Market cap $4.97BP/E –Yield –
Caris Life Sciences Capital Expenditures & Capitalized Software by Quarter
Capital Expenditures & Capitalized Software ($M)
Caris Life Sciences Capital Expenditures & Capitalized Software: $17.5M in Q3 2026, up 146.5% from a year earlier.
Where the Q3 2026 figure comes from
Calculated from reported figures: quarter = year-to-date − previous year-to-date (cash flow statement)
Source: SEC Form 10-Q (0002019410-26-000069, filed 2026-11-04) ↗
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Capital Expenditures & Capitalized Software ($M) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 17.5 | +146.5% | SEC Form 10-Q (0002019410-26-000069, filed 2026-11-04) ↗ |
| Q2 2026 | Jun 30, 2026 | 22.1 | +1,478.6% | SEC Form 10-Q (0002019410-26-000055, filed 2026-08-05) ↗ |
| Q1 2026 | Mar 31, 2026 | 10.3 | +281.5% | SEC Form 10-Q (0002019410-26-000044, filed 2026-05-08) ↗ |
| Q4 2025 | Dec 31, 2025 | 5.10 | +121.7% | SEC Form 10-K (0002019410-26-000016, filed 2026-03-03) ↗ |
| Q3 2025 | Sep 30, 2025 | 7.10 | +294.4% | SEC Form 10-Q (0002019410-25-000028, filed 2025-11-05) ↗ |
| Q2 2025 | Jun 30, 2025 | 1.40 | – | SEC Form 10-Q (0002019410-26-000044, filed 2026-05-08) ↗ |
| Q1 2025 | Mar 31, 2025 | 2.70 | – | SEC Form 10-Q (0002019410-26-000044, filed 2026-05-08) ↗ |
| Q4 2024 | Dec 31, 2024 | 2.30 | – | SEC Form 10-K (0002019410-26-000016, filed 2026-03-03) ↗ |
| Q3 2024 | Sep 30, 2024 | 1.80 | – | SEC Form 10-Q (0002019410-25-000028, filed 2025-11-05) ↗ |
Cite this data
StockData. (2026). Caris Life Sciences Capital Expenditures & Capitalized Software ($M), quarterly Q3 2024–Q3 2026 [Data set]. Compiled from Caris Life Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/cai/kpis/db-capex
See every metric in the Caris Life Sciences KPI table. Data updated Nov 16, 2026.
See a number that looks wrong?